Clinical Trial Update: Empagliflozin in Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 trial update shows empagliflozin is being investigated for hypertrophic cardiomyopathy and heart failure, with the study currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertrophic Cardiomyopathy

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Hypertrophic Cardiomyopathy, Heart Failure | Phase 3 | Status: ACTIVE_NOT_RECRUITING